Delayed hypersensitivity to thimerosal in Rho(D) immunoglobulin

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 1, 1997, Pages 138-139

  Luka, Richard E ^a   Oppenheimer, John J ^a,b   Miller, Naomi ^b   Rossi, Joseph ^b   Bielory, Leonard ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS ANTIGEN; RHESUS D ANTIBODY; THIOMERSAL;

ADULT; ARTICLE; CASE REPORT; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RHESUS INCOMPATIBILITY;

EID: 0030795234     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70206-9     Document Type: Article

References (7)

1. Grabenstein JD. ImmunoFacts: vaccines and immunologic drugs. 1st ed. St. Louis: Facts and Comparisons; 1995. p. 284-9.
2. Fisher AA. Contact dermatitis. 3rd ed. Philadelphia: Lea and Febiger; 1986. p. 178-81.
3. Noel I, Galloway A, Ive FA. Hypersensitivity to thimerosal in hepatitis B vaccine. Lancet 1991;338:705.
4. Rietschel RL, Adams RM. Reactions to thimerosal in hepatitis B vaccines. Dermatol Clin 1990;8:161-4.
5. Lohiya G. Asthma and urticaria after hepatitis B vaccination. West J Med 1987;147:341.
6. Maibach H. Acute laryngeal obstruction presumed secondary to thimerosal (merthiolate) delayed hypersensitivity. Contact Dermatitis 1975:1:221-2.
7. van't Veen AJ, van Joost T. Sensitization to thimerosal (merthiolate) is still present today. Contact Dermatitis 1994;31:293-8.